PNE Effectiveness Cluster Trial (PNE)

July 28, 2020 updated by: Elizabeth Lane, University of Utah

The Effectiveness of Training Physical Therapists in Pain Neuroscience Education on Patient Reported Outcomes for Patients With Chronic Spinal Pain

This is a cluster randomized trial that involves training regions of physical therapy clinics to use pain neuroscience education or continue with usual care. The investigators will examine outcomes for patients with chronic neck or back pain.

Study Overview

Status

Completed

Detailed Description

Chronic spinal pain is a very common and costly condition. An estimated 26.4% of Americans have experienced an episode low back pain (LBP) and 13.8% have experienced neck pain in the past 3 months. Lifetime prevalence of spinal pain ranges from 54% to 80% and the estimated healthcare costs for those with spinal pain are 57% higher than those without. While many with acute LBP have a favorable prognosis, those who develop chronic pain continue will experience persistent poor health and place a large burden on the healthcare system.

With growing healthcare costs and mounting disability, there is increased demand for physical therapists to promote more effective self-management strategies for patients with chronic spinal pain. Education is a critical component of self-management. Pain neuroscience education (PNE) is an education method used by physical therapists to help patients understand the biology, physiology and psychological factors influencing their pain experience and to reconcile faulty cognitions and beliefs associated with persistent pain and disability8. PNE has been shown to have positive effects on patient-reported outcomes for a variety of spinal pain conditions. This study will examine the impact of widespread implementation of PNE into routine physical therapy care.

The proposed mechanism of PNE is proposed to relate changes in patients' conceptualization of the pain experience, specifically concepts associated with fear, knowledge, and beliefs of pain. Additional research has identified autonomous motivation and self-efficacy as relevant to patients' behavioral responses to pain. Autonomous motivation is proposed to be an essential factor for behavior change, adhering to a treatment program and persistent positive health behavior changes. Autonomous motivation has not been examined as an influencing factor in the PNE model. Self-efficacy relates to the degree an individual feels they have control over their situation; and high self-efficacy has been associated with more active coping efforts. This study will examine self-efficacy and autonomous motivation as potential mediators of the ability of a PNE intervention improve functional outcomes in a pragmatic clinical environment.

This project's overall goal is to determine the effectiveness of providing physical therapists with PNE training on patient-centered outcomes (physical function and pain interference) for patients with chronic neck or back pain receiving physical therapy. Secondarily, the investigators will explore mechanisms of effects of PNE by examining the role of autonomous motivation and self-efficacy. To accomplish these goals, the investigators will conduct a cluster-randomized clinical trial, randomly assigning groups of clinics to receive PNE training or usual care with no additional training for physical therapists working in the clinic. This design allows for maximum external validity and generalizability across outpatient physical therapy clinics.

Primary Aims I. Compare effectiveness of PNE training vs. no additional training for physical therapists on patient-centered outcomes (physical function and pain interference) for patients with chronic spinal pain. The investigators hypothesize patients receiving treatment from physical therapists receiving PNE education will show greater improvement in patient-centered outcomes.

Secondary Aims I. Compare the effects of PNE training vs. no additional training for physical therapists on the patient-physical therapist alliance. The investigators hypothesize patients receiving treatment from physical therapists receiving PNE education will show greater alliance with their physical therapist.

II. Explore the mediating effects of autonomous motivation and self-efficacy on patient-centered outcomes. The investigators hypothesize autonomous motivation and/or self-efficacy will mediate the effects of education on patient-centered outcomes.

Study Type

Interventional

Enrollment (Actual)

316

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35242-8601
        • BenchMark
      • Birmingham, Alabama, United States, 35243-2366
        • BenchMark
      • Helena, Alabama, United States, 35080-3773
        • BenchMark
      • Hoover, Alabama, United States, 35244-1254
        • BenchMark
      • Moody, Alabama, United States, 35004-3101
        • BenchMark
      • Phenix City, Alabama, United States, 36867-7484
        • BenchMark
    • Georgia
      • Acworth, Georgia, United States, 30101-8352
        • Benchmark Physical Therapy
      • Alpharetta, Georgia, United States, 30005-4202
        • BenchMark
      • Atlanta, Georgia, United States, 30306-4530
        • BenchMark
      • Atlanta, Georgia, United States, 30308-1245
        • BenchMark
      • Atlanta, Georgia, United States, 30316-6833
        • BenchMark
      • Atlanta, Georgia, United States, 30318-3117
        • BenchMark
      • Atlanta, Georgia, United States, 30319
        • BenchMark
      • Atlanta, Georgia, United States, 30342-1461
        • BenchMark
      • Austell, Georgia, United States, 30106-8531
        • BenchMark
      • Canton, Georgia, United States, 30114-5603
        • BenchMark
      • Canton, Georgia, United States, 30115-9376
        • BenchMark
      • Carrollton, Georgia, United States, 30117-4456
        • BenchMark
      • Cartersville, Georgia, United States, 30121-3305
        • BenchMark
      • Columbus, Georgia, United States, 31909-5649
        • BenchMark
      • Dallas, Georgia, United States, 30157-4702
        • BenchMark
      • Decatur, Georgia, United States, 30033-5305
        • BenchMark
      • Dunwoody, Georgia, United States, 30338-4163
        • BenchMark
      • Hiram, Georgia, United States, 30141-2692
        • BenchMark
      • Jasper, Georgia, United States, 30143-8704
        • BenchMark
      • Kennesaw, Georgia, United States, 30144-3210
        • BenchMark
      • Lawrenceville, Georgia, United States, 30046-8767
        • Rehab South
      • Marietta, Georgia, United States, 30060-9412
        • BenchMark
      • Marietta, Georgia, United States, 30062-4197
        • BenchMark
      • Marietta, Georgia, United States, 30064-5037
        • BenchMark
      • Marietta, Georgia, United States, 30067-8642
        • BenchMark
      • Marietta, Georgia, United States, 30068-5418
        • BenchMark
      • Newnan, Georgia, United States, 30265-6506
        • Rehab South
      • Peachtree City, Georgia, United States, 30269-1571
        • Rehab South
      • Peachtree City, Georgia, United States, 30269
        • BenchMark
      • Roswell, Georgia, United States, 30075-7524
        • BenchMark
      • Roswell, Georgia, United States, 30076-0929
        • BenchMark
      • Roswell, Georgia, United States, 30076-3866
        • BenchMark
      • Smyrna, Georgia, United States, 30080-9213
        • BenchMark
      • Suwanee, Georgia, United States, 30024-9104
        • BenchMark
      • Tucker, Georgia, United States, 30084-4916
        • BenchMark

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18-75 at time of first physical therapy session
  • Primary reason for physical therapy is low back and/or neck pain
  • Meets the NIH definition of chronic pain (i.e., neck or back pain on at least half the days in the past 6 months.)

Exclusion Criteria:

  • No spinal surgery within the previous 12 months
  • No evidence of "red flag" conditions (e.g., cauda equine syndrome, cancer, fracture, infection or systemic disease) that requires immediate referral from physical therapy to medical care
  • Not currently known to be pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual Care
Usual care, no intervention
Experimental: Pain Neuroscience Education Training
The region of clinics randomized to this arm will receive PNE education, which consists of 6 weeks online training followed by an on-site training day.
PNE training will consist of 6 weeks online training followed by one day training session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function
Time Frame: 2 week and 12 week
Change score of Physical Function scores from baseline
2 week and 12 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference
Time Frame: 2 week and 12 week
Change score of Pain Interference scores from baseline
2 week and 12 week
pain self-efficacy
Time Frame: 2 week and 12 week
Measured by Pain Self-Efficacy Questionnaire
2 week and 12 week
Autonomous motivation
Time Frame: 2 week and 12 week
Measured by Treatment Self-regulation Questionnaire
2 week and 12 week
Therapeutic Alliance
Time Frame: 2 week and 12 week
As measured by Working Alliance Theory of Change Inventory
2 week and 12 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 24, 2017

Primary Completion (Actual)

June 1, 2019

Study Completion (Actual)

June 1, 2019

Study Registration Dates

First Submitted

May 23, 2017

First Submitted That Met QC Criteria

May 24, 2017

First Posted (Actual)

May 30, 2017

Study Record Updates

Last Update Posted (Actual)

July 29, 2020

Last Update Submitted That Met QC Criteria

July 28, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 00097154

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Pain neuroscience education training

Subscribe